Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
hepatocellular_carcinoma [2019/10/18 16:19] – [Data] adminhepatocellular_carcinoma [2019/10/18 16:50] – [Data] admin
Line 14: Line 14:
   - Sequencing was completed by Beckman Coulter using [[http://www.illumina.com/products/truseq_rna_library_prep_kit_v2.html|TruSeq RNA Library Preparation Kit v2]] which is an unstranded protocol.   - Sequencing was completed by Beckman Coulter using [[http://www.illumina.com/products/truseq_rna_library_prep_kit_v2.html|TruSeq RNA Library Preparation Kit v2]] which is an unstranded protocol.
   - Jielei provided TruSeq {{:illumina_stranded_rnaseq_mapping.pdf|Stranded}}  RNA-Seq data from 8 mice in August 2017 (See ~/proj/hcc/data/TPT1/readme.txt), which was analyzed using TruSeq Stranded RNA-Seq.   - Jielei provided TruSeq {{:illumina_stranded_rnaseq_mapping.pdf|Stranded}}  RNA-Seq data from 8 mice in August 2017 (See ~/proj/hcc/data/TPT1/readme.txt), which was analyzed using TruSeq Stranded RNA-Seq.
-  - Gao, Qiang, et al. "Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma." //[[https://www.sciencedirect.com/science/article/pii/S0092867419310037|Cell//]]// 179.2 (2019): 561-577. \\  "The data of WES, transcriptome sequencing, proteome, and phosphoproteome are available in [[https://www.biosino.org/node|NODE]] (accession # [[https://www.biosino.org/node/experiment/detail/OEX001697|OEP000321]]).+  - Gao, Qiang, et al. "Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma." //[[https://www.sciencedirect.com/science/article/pii/S0092867419310037|Cell//]]// 179.2 (2019): 561-577. \\ "The data of WES, transcriptome sequencing, proteome, and phosphoproteome are available in [[https://www.biosino.org/node|NODE]] (accession # [[https://www.biosino.org/node/experiment/detail/OEX001697|OEP000321]]). Survival data (~5 years of followup) were included in Table S1.